Thursday, November 28, 2013

You might think that he would see that


BCG is easily and widely and inexpensively made available to the citizens of the United States?
see eg pubmed.org  faustman dl and /or faustmanlab.org


Dr. Burke should contemplate that the US was once able to treat the cause of causalgia and is presently unable to do so.

See The Lancet p.106 Jan. 14, 1978 describing the treatment of the cause of causalgia as witnessed by the patient, Mrs. J Edward Spike Jr.,'s, personal physician Mark Altschule MD of Harvard Medical School.



UPMC/University of Pittsburgh Schools of the Health Sciences
Donald S. Burke, MD
For Journalists
Managers
Telephone: 412-647-9975

 
Other Inquiries

Donald  S.  Burke, MD

  • Dean of the University of Pittsburgh Graduate School of Public Health (GSPH)
  • Director of the University of Pittsburgh Center for Vaccine Research 
  • Associate Vice Chancellor for Global Health, Health Sciences
  • Jonas Salk Professor of Global Health at the University of Pittsburgh Medical Center
​ Donald S. Burke, MD, dean of the University of Pittsburgh Graduate School of Public Health (GSPH), is one of the world’s foremost experts in prevention, diagnosis and control of infectious diseases of global concern, including HIV/AIDS, hepatitis A, avian influenza and emerging infectious diseases.
In addition to serving as dean of GSPH, Dr. Burke is director of the University of Pittsburgh Center for Vaccine Research and serves in the newly established position of associate vice chancellor for global health, health sciences. He also is the first University of Pittsburgh Medical Center-Jonas Salk Professor of Global Health.
Before joining the University of Pittsburgh, Dr. Burke was a professor at the Johns Hopkins Bloomberg School of Public Health, where he served as associate chair of the department of international health and director of the Center for Immunization Research. He also was principal investigator of National Institutes of Health-supported research projects on HIV vaccines, biodefense and emerging infectious diseases.
Prior to his tenure at Johns Hopkins, Dr. Burke served 23 years on active duty in the U.S. Army, leading military infectious disease research at the Walter Reed Army Institute of Research in Washington, D.C., and at the Armed Forces Research Institute of Medical Sciences in Bangkok, Thailand. He retired at the rank of colonel.
Dr. Burke’s career-long mission has been prevention and mitigation of the impact of epidemic infectious diseases of global importance. His research activities have spanned a wide range of science “from the bench to the bush,” including development of new diagnostics, population-based field studies, clinical vaccine trials, computational modeling of epidemic control strategies and policy analysis. He has authored or co-authored more than 200 research reports

No comments:

Post a Comment